Journal article
Global Cancer Surgery: Delivering Safe, Affordable, and Timely Cancer Surgery
Richard Sullivan, Olusegun Isaac Alatise, Benjamin O Anderson, Riccardo Audisio, Philippe Autier, Ajay Aggarwal, Charles Balch, Murray F Brennan, Anna Dare, Anil D'Cruz, Alexander MM Eggermont, Kenneth Fleming, Serigne Magueye Gueye, Lars Hagander, Cristian A Herrera, Hampus Holmer, Andre M Ilbawi, Anton Jarnheimer, Jia-fu Ji, T Peter Kingham Show all
The Lancet Oncology | Elsevier | Published : 2015
Abstract
Surgery is essential for global cancer care in all resource settings. Of the 15·2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide. Yet, less than 25% of patients with cancer worldwide actually get safe, affordable, or timely surgery. This Commission on global cancer surgery, building on Global Surgery 2030, has examined the state of global cancer surgery through an analysis of the burden of surgical disease and breadth of cancer surgery, economics and financing, factors for strengthening surgical systems for cancer with multiple-country studies, the researc..
View full abstractGrants
Funding Acknowledgements
We thank the editorial staff of The Lancet Oncology, particularly Rob Brierley, and the anonymous referees for outstanding peer review. RS thanks the National Cancer Institute Centre for Global Health for their core support. SVS thanks B Ganesh (Tata Memorial Hospital, Mumbai, India) for expert inputs. GPP thanks Mulindi H Mwanahamuntu, Michael L Hicks, Ronda Henry-Tillman, and Vikrant V Sahasrabuddhe for help with analysis of scaling up cancer surgery and for giving insightful perspectives on surgery for cancers and cancer surgery in low-resource settings. We thank E M de Leede for contributions to research analysis. SW thanks Jiang Kewei (Department of Gastroenterological Surgery); Wang Jun, Jiang Guanchao, Yang Fan, and Zhou Jian (Department of Thoracic Surgery), and Wang Shu and Cheng Lin (Breast Disease Center) from Peking University People's Hospital (Beijing, China), for giving insightful perspectives, collecting statistical data, and providing figures on the state of cancer surgery in China. Finally, we thank the Union for International Cancer Control for their support.